Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
7-methylxanthine
- Development stage
- Phase 2
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**7-methylxanthine** is a methylated derivative of xanthine and an active metabolite of caffeine and theobromine. It acts as a non-selective antagonist of adenosine receptors (including A1, A2A, and A2B subtypes), thereby modulating neurotransmission and smooth muscle tone. It is found occasionally in human urine as a result of purine metabolism. Clinically, it has been investigated for its potential to slow the progression of myopia (nearsightedness) in children by retarding axial elongation of the eye. Studies suggest that systemic treatment with 7-methylxanthine may be safe and effective for this purpose[3][5][8]. The compound exhibits low toxicity and no carcinogenic effects[8].
- Other names
- 7-MXHeteroxanthinHeteroxanthine7-MethylxanthinXanthine, 7-methyl-2,6-dihydroxy-7-methylpurine
02
Targets
ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)ADORA2B (Adenosine A2B receptor)
Beyond the preview
Go deeper on 7-methylxanthine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 7-methylxanthine.